Ceftibuten is an orally administered cephalosporin with exceptional beta-lactamase stability and potency against commonly isolated Gram-negative pathogens. More than 90% of recent Enterobacteriaceae clinical isolates were inhibited by < or = 8 micrograms/ml of ceftibuten. References: Demirel I, Kruse R, Onnberg A, Persson K. Ceftibuten-induced filamentation of extended spectrum beta lactamase (ESBL)-producing uropathogenic Escherichia coli alters host cell responses during an in vitro infection. Microb Pathog. 2015 Jan;78:52-62. doi: 10.1016/j.micpath.2014.11.015. Epub 2014 Nov 27. PubMed PMID: 25433242.

纯度：≥98%

CAS：97519-39-6